The causes of Charcot-Marie-Tooth disease

Cellular and Molecular Life Sciences

Volumn 60, Issue 12, 2003, Pages 2547-2560

  Young, P ^a,b   Suter, U ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ETH ZURICH   (Switzerland)

Author keywords

Axon degeneration; Charcot Marie Tooth disease; Hereditary neuropathy; Myelin; Neurodegeneration; Peripheral nervous system; Schwann cell

Indexed keywords

GAP JUNCTION PROTEIN; LAMIN A; LAMIN C; MYELIN; MYELIN PROTEIN; PROTEIN;

CX32 GENE; EGR2 GENE; GDAP1 GENE; GENE; GENE MUTATION; GJB1 GENE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; KROX20 GENE; MOTOR NERVE; MPZ GENE; MTMR13 GENE; MTMR2 GENE; NDRG1 GENE; NEFL GENE; NERVE FIBER DEGENERATION; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PMP22 GENE; PRX GENE; QUALITY OF LIFE; RAB7 GENE; REVIEW; SCHWANN CELL; SENSORY NERVE;

CHARCOT-MARIE-TOOTH DISEASE; GENETIC HETEROGENEITY; HUMANS; MYELIN PROTEINS;

EID: 0346100497     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3133-5     Document Type: Review

References (207)

1. Skre H. (1974) Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet. 6: 98-118
2. Charcot J.-M. and Marie P. (1886) Sur une forme particuliére d'atrophie musculaire progressive, souvent familiale, debutant par les pieds et les jambes et atteignant plus tard les mains. Rev. Méd. 6: 97-138
3. Tooth H. H. (1886) The Peroneal Type of Progressive Muscular Atrophy, H. K. Lewis, London
4. Kuhlenbaumer G., Young P., Hunermund G., Ringelstein B. and Stogbauer F. (2002) Clinical features and molecular genetics of hereditary peripheral neuropathies. J. Neurol. 249: 1629-1650
5. Dyck P. J., Chance P., Lebo R. and Carney J. A. (1993) Hereditary motor And sensory neuropathy. In: Peripheral Neuropathy 3, pp. 1094-1136, Dyck P. J. and Thomas P. K. (eds), W. B. Saunders, Philadelphia
6. Maier M., Berger P. and Suter U. (2002) Understanding Schwann cell-neurone interactions: the key to Charcot-Marie-Tooth disease? J. Anat. 200: 357-366
7. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P. E. et al. (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33: 366-374
8. Dyck P. J. and Lambert E. H. (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy I. Neurologic, genetic and electrophysiologic findings in hereditary polyneuropathies. Arch. Neurol. 18: 603-618
9. Lupski J., de Oca-Luna R., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B. et al. (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66: 219-232
10. Raeymaekers P., Timmerman V., Nelis E., De Jonghe P., Hoogendijk J. E., Baas F. et al. (1991) Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul. Disord. 1: 93-97
11. Suter U., Welcher A. A., Ozcelik T., Snipes G. J., Kosaras B., Francke U. et al. (1992) Trembler mouse carries a point mutation in a myelin gene. Nature 356: 241-244
12. Suter U., Moskow J. J., Welcher A. A., Snipes G. J., Kosaras B., Sidman R. L. et al. (1992) A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl. Acad. Sci. USA 89: 4382-4386
13. Matsunami N., Smith B., Ballard L., Lensch M., Robertson M., Albertsen H. et al. (1992) Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat. Genet. 1: 176-179
14. Valentijn L., Bolhuis P., Zorn I., Hoogendijk J., van den Bosch N., Hensels G. et al. (1992) The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1: 166-170
15. Timmerman V., Nelis E., Van Hul W., Nieuwenhuijsen B., Chen K., Wang S. et al. (1992) The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat. Genet. 1: 171-175
16. Patel P., Roa B., Welcher A., Schoener-Scott R., Trask B., Pentao L. et al. (1992) The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1: 159-165
17. Magyar J., Martini R., Ruelicke T., Aguzzi A., Adlkofer K., Dembic Z. et al. (1996) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16: 5351-5360
18. Sereda M., Griffiths I., Puhlhofer A., Stewart H., Rossner M. J., Zimmerman F. et al. (1996) A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16: 1049-1060
19. Suter U. and Snipes G. (1995) Biology and Genetics of hereditary motor and sensory Neuropathies. Annu. Rev. Neurosci. 18: 45-75
20. Martini R. (2001) The effect of myelinating Schwann cells on axons. Muscle Nerve 24: 456-466
21. Berger P., Young P. and Suter U. (2002) Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics 4: 1-15
22. Young P. and Suter U. (2001) Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease. Brain Res. Brain Res. Rev. 36: 213-221
23. Nelis E., Van Broeckhoven C., De J. P., Lofgren A., Vandenberghe A., Latour P. et al. (1996) Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur. J. Hum. Genet. 4: 25-33
24. Chance P., Alderson M., Leppig K., Lensch M., Matsunami N., Smith B. et al. (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72: 143-151
25. Stögbauer F., Young P., Kuhlenbäumer G., De Jonghe P. and Timmerman V. (2000) Hereditary recurrent focal neuropathies: clinical and molecular features. Neurology 54: 546-551
26. Stögbauer F. and Van Broeckhoven C. (2000) Hereditary recurrent focal neuropathies (6th Workshop of the European Charcot-Marie-Tooth Disease Consortium). Neuromuscular Disorders 10: 518-524
27. Windebank A. (1993) Inherited recurrent focal neuropathies. In: Peripheral Neuropathy, 3rd edn, pp. 1137-1148, Dyck P., Thomas P. and Griffin J. (eds), W. B. Saunders, Philadelphia
28. Nicholson G., Valentijn L., Cherryson A., Kennerson M., Bragg T., DeKroon R. et al. (1994) A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat. Genet. 6: 263-266
29. Young P., Wiebusch H., Stögbauer F., Ringelstein B., Assmann G. and Funke H. (1997) A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology 48: 450-452
30. Gabreels-Festen A. and Wetering R. V. (1999) Human nerve pathology caused by different mutational mechanisms of the PMP22 gene. Ann. N. Y. Acad. Sci. 883: 336-343
31. Gabreels-Festen A. and Gabreels F. (1993) Hereditary demyelinating motor and sensory neuropathy. Brain Pathol. 3: 135-146
32. Thomas P. K., King R. H., Small J. R. and Robertson A. M. (1996) The pathology of Charcot-Marie-Tooth disease and related disorders. Neuropathol. Appl. Neurobiol. 22: 269-284
33. Berciano J., Garcia A., Calleja J. and Combarros O. (2000) Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with charcot-marie-tooth disease 1A duplication. Neuromuscul. Disord. 10: 419-424
34. Krajewski K., Turansky C., Lewis R., Garbern J., Hinderer S., Kamholz J. et al. (1999) Correlation between weakness and axonal loss in patients with CMT1A. Ann. N. Y. Acad. Sci. 883: 490-492
35. Krajewski K. M., Lewis R. A., Fuerst D. R., Turansky C., Hinderer S. R., Garbern J. et al. (2000) Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123: 1516-1527
36. LeGuern E., Gouider R., Mabin D., Tardieu S., Birouk N., Parent P. et al. (1997) Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease. Ann. Neurol.41: 104-108
37. Lupski J., Wise C., Kuwano A., Pentao L., Parke J., Glaze D. et al. (1992) Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1: 29-33
38. Naef R. and Suter U. (1999) Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol. Dis. 6: 1-14
39. Lupski J. R. (2000) Recessive Charcot-Marie-Tooth disease. Ann. Neurol. 47: 6-8
40. Parman Y., Plante-Bordeneuve V., Guiochon-Mantel A., Eraksoy M. and Said G. (1999) Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine-Sottas disease. Ann. Neurol. 45: 518-522
41. Roa B. B., Dyck P. J., Marks H. G., Chance P. F. and Lupski J. R. (1993) Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat. Genet. 5: 269-273
42. Valentijn L. J., Ouvrier R. A., van den Bosch N. H., Bolhuis P. A., Baas F. and Nicholson G. A. (1995) Dejerine-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum. Mutat. 5: 76-80
43. Suter U. and Nave K. A. (1999) Transgenic mouse models of CMT1A and HNPP. Ann. N. Y. Acad. Sci. 883: 247-253
44. Adlkofer K., Frei R., Neuberg D. H., Zielasek J., Toyka K. V. and Suter U. (1997) Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J. Neurosci. 17: 4662-4671
45. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K. V. and Suter U. (1995) Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet. 11: 274-280
46. Adlkofer K., Naef R. and Suter U. (1997) Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. J. Neurosci. Res. 49: 671-680
47. Huxley C., Passage E., Manson A., Putzu G., Figarella-Branger D., Pellissier J. F. et al. (1996) Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5: 563-569
48. Niemann S., Sereda M. W., Rossner M., Stewart H., Suter U., Meinck H. M. et al. (1999) The 'CMT rat': peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22. Ann. N. Y. Acad. Sci. 883: 254-261
49. Robertson A. M., Perea J., McGuigan A., King R. H., Muddle J. R., Gabreels-Festen A. A. et al. (2002) Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J. Anat. 200: 377-390
50. Suh J. G., Ichihara N., Saigoh K., Nakabayashi O., Yamanishi T., Tanaka K. et al. (1997) An in-frame deletion in peripheral myelin protein-22 gene causes hypomyelination and cell death of the Schwann cells in the new Trembler mutant mice. Neuroscience79: 735-744
51. Isaacs A. M., Davies K. E., Hunter A. J., Nolan P. M., Vizor L., Peters J. et al. (2000) Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum. Mol. Genet. 9: 1865-1871
52. Isaacs A. M., Jeans A., Oliver P. L., Vizor L., Brown S. D., Hunter A. J. et al. (2002) Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy. Mol. Cell. Neurosci. 21: 114-125
53. Taylor V., Zgraggen C., Naef R. and Suter U. (2000) Membrane topology of peripheral myelin protein 22. J. Neurosci. Res 62: 15-27
54. Spreyer P., Kuhn G., Hanemann C. O., Gillen C., Schaal H., Kuhn R. et al. (1991) Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene. EMBO J. 10: 3661-3668
55. Welcher A. A., Suter U., De Leon M., Snipes G. J. and Shooter E. M. (1991) A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc. Natl. Acad. Sci. USA 88: 7195-7199
56. Snipes G. J., Suter U., Welcher A. A. and Shooter E. M. (1992) Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J. Cell Biol. 117: 225-238
57. D'Urso D., Schmalenbach C., Zoidl G., Prior R. and Muller H. W. (1997) Studies on the effects of altered PMP22 expression during myelination in vitro. J. Neurosci. Res. 48: 31-42
58. Hanemann C. O., Rosenbaum C., Kupfer S., Wosch S., Stoegbauer F. and Müller H. W. (1998) Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients. Glia 22: 89-98
59. Zoidl G., Blass-Kampmann S., D'Urso D., Schmalenbach C. and Muller H. (1995) Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells modulation of cell growth. EMBO J. 14: 1122-1128
60. Fabbretti E., Edomi P., Brancolini C. and Schneider C. (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev. 9: 1846-1856
61. Brancolini C., Marzinotto S., Edomi P., Agostoni E., Fiorentini C., Muller H. W. et al. (1999) Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol. Biol. Cell 10: 2441-2459
62. Hanemann C. O., Gabreels-Fasten A. A., Muller H. W. and Stoll G. (1996) Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages. Brain 119: 1461-1469
63. Hanemann C. O., Gabreels-Festen A. A., Stoll G. and Müller H. W. (1997) Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs. Acta Neuropathol. 94: 310-315
64. Brancolini C., Edomi P., Marzinotto S. and Schneider C. (2000) Exposure at the cell surface is required for gas3/PMP22 to regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases. Mol. Biol. Cell 11: 2901-2914
65. Chies R., Nobbio L., Edomi P., Schenone A., Schneider C. and Brancolini C. (2003) Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22. J. Cell Sci. 116: 987-999
66. Notterpek L., Roux K. J., Amici S. A., Yazdanpour A., Rahner C. and Fletcher B. S. (2001) Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc. Natl. Acad. Sci. USA 98: 14404-14409
67. Takeda Y., Notsu T., Kitamura K. and Uyemura K. (2001) Functional analysis for peripheral myelin protein PASII/ PMP22: is it a member of claudin superfamily? Neurochem. Res. 26: 599-607
68. Jetten A. M. and Suter U. (2000) The peripheral myelin protein 22 and epithelial membrane protein family. Prog. Nucleic Acid Res. Mol. Biol. 64: 97-129
69. D'Urso D., Ehrhardt P. and Muller H. W. (1999) Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J. Neurosci. 19: 3396-3403
70. ToblerA. R., Liu N., Mueller L. and Shooter E. M. (2002) Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22. Proc. Natl. Acad. Sci. USA 99: 483-488
71. Hanemann C. O. and Müller H. W. (1998) Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy. Trends Neurosci. 21: 282-286
72. Sancho S., Young P. and Suter U. (2001) Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Brain 124: 2177-2187
73. Perea J., Robertson A., Tolmachova T., Muddle J., King R. H., Ponsford S. et al. (2001) Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum. Mol. Genet. 10: 1007-1018
74. Sancho S., Magyar J. P., Aguzzi A. and Suter U. (1999) Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 122: 1563-1577
75. Norreel J. C., Vinay L., Fontes M. and Clarac F. (2003) Close relationship between motor impairments and loss of functional motoneurons in a Charcot-Marie-Tooth type 1A model. Neuroscience 116: 695-703
76. Colby J., Nicholson R., Dickson K. M., Orfali W., Naef R., Suter U. et al. (2000) PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol. Dis. 7: 561-573
77. Dickson K. M., Bergeron J. J., Shames I., Colby J., Nguyen D. T., Chevet E. et al. (2002) Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for 'gain-of-function' ER diseases. Proc. Natl. Acad. Sci. USA 99: 9852-9857
78. Naef R., Adlkofer K., Lescher B. and Suter U. (1997) Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol. Cell. Neurosci. 9: 13-25
79. Notterpek L., Shooter E. M. and Snipes G. J. (1997) Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J. Neurosci. 17: 4190-4200
80. Tobler A. R., Notterpek L., Naef R., Taylor V., Suter U. and Shooter E. M. (1999) Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J. Neurosci. 19: 2027-2036
81. Southwood C. M., Garbern J., Jiang W. and Gow A. (2002) The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36: 585-596
82. Ryan M. C., Shooter E. M. and Notterpek L. (2002) Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol. Dis. 10: 109-118
83. Notterpek L., Ryan M. C., Tobler A. R. and Shooter E. M. (1999) PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiol. Dis. 6: 450-460
84. Street V. A., Bennett C. L., Goldy J. D., Shirk A. J., Kleopa K. A., Tempel B. L. et al. (2003) Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 60: 22-26
85. Bird T., Ott J. and Giblett E. (1982) Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am. J. Hum. Genet. 34: 388-394
86. Hayasaka K., Himoro M., Sawaishi Y., Nanao K., Takahashi T., Takada G. et al. (1993) De novo mutation of the myelin Po gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat. Genet. 5: 266-268
87. Hayasaka K., Himoro M., Takada G., Takahashi E., Minoshima S. and Shimizu N. (1993) Structure and localization of the gene encoding human peripheral myelin protein 2 (PMP2). Genomics 18: 244-248
88. Hayasaka K., Ohnishi A., Takada G., Fukushima Y. and Murai Y. (1993) Mutation of the myelin PO gene in Charcot-Marie-Tooth neuropathy type 1. Biochem. Biophys. Res. Commun. 194: 1317-1322
89. 0) mutations may include Charcot-Marie-Tooth Type 1B, Dejerine-Sottas and congenital hypomyelination. Neuron 17: 451-460
90. Lemke G. and Axel R. (1985) Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40: 501-508
91. D'Urso D., Brophy P. J., Staugaitis S. M., Gillespie C. S., Frey A. B., Stempak J. G. et al. (1990) Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion and evidence for homotypic interaction. Neuron 4: 449-460
92. Filbin M. T., Walsh F. S., Trapp B. D., Pizzey J. A. and Tennekoon G. I. (1990) Role of myelin P0 protein as a homophilic adhesion molecule. Nature 344: 871-872
93. Giese K. P., Martini R., Lemke G., Soriano P. and Schachner M. (1992) Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71: 565-576
94. Martini R., Zielasek J., Toyka K., Giese P. and Schachner M. (1995) Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 11: 281-286
95. Schneider-Schaulies J., von Brunn A. and Schachner M. (1990) Recombinant peripheral myelin protein P0 confers both adhesion and neurite outgrowth-promoting properties. J. Neurosci. Res. 27: 286-297
96. Shapiro L., Doyle J. P., Hensley P., Colman D. R. and Hendrickson W. A. (1996) Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17: 435-449
97. Suter U. (1997) Myelin: keeping nerves well wrapped up. Curr. Biol. 7: R21-23
98. Young P., Grote K., Kuhlenbäumer G., Debus O., Kurlemann H., Halfter H. et al. (2001) Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity. J. Neurol. 248: 410-415
99. Matsuyama W., Nakagawa M., Takashima H. and Osame M. (2002) Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B. Acta Neuropathol. 103: 501-508
100. Xu W., Shy M., Kamholz J., Elferink L., Xu G., Lilien J. et al. (2001) Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination. J. Cell Biol. 155: 439-446
101. Marrosu M. G., Vaccargiu S., Marrosu G., Vannelli A., Cianchetti C. and Muntoni F. (1998) Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 50: 1397-1401
102. Chapon F., Latour P., Diraison P., Schaeffer S. and Vandenberghe A. (1999) Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J. Neurol. Neurosurg. Psychiatry 66: 779-782
103. De Jonghe P., Timmerman V., Ceuterick C., Nelis E., De Vriendt E., Lofgren A. et al. (1999) The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 122: 281-290
104. Senderek J., Hermanns B., Lehmann U., Bergmann C., Marx G., Kabus C. et al. (2000) Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible hotspot on Thr124Met. Brain Pathol. 10: 235-248
105. Hanemann C. O., Gabreels-Festen A. A. and De Jonghe P. (2001) Axon damage in CMT due to mutation in myelin protein P0. Neuromuscul. Disord. 11: 753-756
106. Misu K., Yoshihara T., Shikama Y., Awaki E., Yamamoto M., Hattori N. et al. (2000) An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J. Neurol. Neurosurg. Psychiatry 69: 806-811
107. Wrabetz L., Feltri M. L., Quattrini A., Imperiale D., Previtali S., D'Antonio M. et al. (2000) P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J. Cell Biol. 148: 1021-1034
108. Previtali S. C., Quattrini A., Fasolini M., Panzeri M. C., Villa A., Filbin M. T. et al. (2000) Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice. J. Cell Biol. 151: 1035-1046
109. Myokai F., Takashiba S., Lebo R. and Amar S. (1999) A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization and chromosomal assignment. Proc. Natl. Acad. Sci. USA 96: 4518-4523
110. Moriwaki Y., Begum N. A., Kobayashi M., Matsumoto M., Toyoshima K. and Seya T. (2001) Mycobacterium bovis Bacillus Calmette-Guerin and its cell wall complex induce a novel lysosomal membrane protein, SIMPLE, that bridges the missing link between lipopolysaccharide and p53-inducible gene, LITAF(PIG7), and estrogen-inducible gene, EET-1. J. Biol. Chem. 276: 23065-23076
111. Wegner M. (2000) Transcriptional control in myelinating glia: flavors and spices. Glia 31: 1-14
112. Pingault V., Guiochon-Mantel A., Bondurand N., Faure C., Lacroix C., Lyonnet S. et al. (2000) Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: a developmental 'neural crest syndrome' related to a SOX10 mutation. Ann. Neurol. 48: 671-676
113. Inoue K., Shilo K., Boerkoel C. F., Crowe C., Sawady J., Lupski J. R. et al. (2002) Congenital hypomyelinating neuropathy, central dysmyelination and Waardenburg-Hirschsprung disease: phenotypes linked by SOX10 mutation. Ann. Neurol. 52: 836-842
114. Inoue K., Tanabe Y. and Lupski J. R. (1999) Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann. Neurol. 46: 13-18
115. Bellone E., Di Maria E., Soriani S., Varese A., Doria L. L., Ajmar F. et al. (1999) A novel mutation (D305V) in the early growth response 2 gene is associated with severe CharcotMarie-Tooth type 1 disease. Hum. Mutat. 14: 353-354
116. Warner L. E., Mancias P., Butler I. J., McDonald C. M., Keppen L., Koob K. G. et al. (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 18: 382-384
117. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A. B., Seitanidou T. et al. (1994) Krox20 controls myelination in the peripheral nervous system. Nature 371: 796-799
118. Nagarajan R., Svaren J., Le N., Araki T., Watson M. and Milbrandt J. (2001) EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30: 355-368
119. Zorick T. S., Syroid D. E., Brown A., Gridley T. and Lemke G. (1999) Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development 126: 1397-1406
120. Warner L. E., Svaren J., Milbrandt J. and Lupski J. R. (1999) Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum. Mol. Genet. 8: 1245-1251
121. Scherer S. S., Xu Y. T., Nelles E., Fischbeck K., Willecke K. and Bone L. J. (1998) Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 24: 8-20
122. Hahn A. F., Ainsworth P. J., Bolton C. F., Bilbao J. M. and Vallat J. M. (2001) Pathological findings in the x-linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathol. 101: 129-139
123. Sander S., Nicholson G. A., Ouvrier R. A., McLeod J. G. and Pollard J. D. (1998) Charcot-Marie-Tooth disease: histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1). Muscle Nerve 21: 217-225
124. Vital A., Ferrer X., Lagueny A., Vandenberghe A., Latour P., Goizet C. et al. (2001) Histopathological features of X-linked Charcot-Marie-Tooth disease in 8 patients from 6 families with different connexin32 mutations. J. Peripher. Nerv. Syst. 6: 79-84
125. Bergoffen J., Scherer S. S., Wang S., Scott M. O., Bone L. J., Paul D. L. et al. (1993) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262: 2039-2042
126. Dubourg O., Barhoumi C., Azzedine H., Birouk N., Brice A., Bouche P. et al. (2001) Phenotypic and genetic study of a fam-ily with hereditary sensory neuropathy and prominent weakness. Muscle Nerve 23: 1508-1514
127. Nakagawa M., Takashima H., Umehara F., Arimura K., Miyashita F., Takenouchi N. et al. (2001) Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence. J. Neurol. Sci. 185: 31-37
128. Kleopa K. A., Yum S. W. and Scherer S. S. (2002) Cellular mechanisms of connexin32 mutations associated with CNS manifestations. J. Neurosci. Res. 68: 522-534
129. Lee M. J., Nelson I., Houlden H., Sweeney M. G., Hilton-Jones D., Blake J. et al. (2002) Six novel connexin32 (GJB1) mutations in X-linked Charcot-Marie-Tooth disease. J. Neurol. Neurosurg. Psychiatry 73: 304-306
130. Panas M., Karadimas C., Avramopoulos D. and Vassilopoulos D. (1998) Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutations. J. Neurol. Neurosurg. Psychiatry 65: 947-948
131. Marques W. Jr, Sweeney J. G., Wood N. W., Wroe S. J. and Marques W. (1999) Central nervous system involvement in a novel connexin 32 mutation affecting identical twins. J. Neurol. Neurosurg. Psychiatry 66: 803-804
132. Scherer S. S., Deschenes S. M., Xu Y. T., Grinspan J. B., Fis-chbeck K. H. and Paul D. L. (1995) Connexin32 is a myelin-relatedprotein in the PNS and CNS. J. Neurosci. 15: 8281-8294
133. Balice-Gordon R. J., Bone L. J. and Scherer S. S. (1998) Functional gap junctions in the schwann cell myelin sheath. J. Cell Biol. 142: 1095-1104
134. Li X., Lynn B. D., Olson C., Meier C., Davidson K. G., Yasumura T. et al. (2002) Connexin29 expression, immunocytochemisrry and freeze-fracture replica immunogold labelling (FRIL) in sciatic nerve. Eur. J. Neurosci. 16: 795-806
135. Altevogt B. M., Kleopa K. A., Postma F. R., Scherer S. S. and Paul D. L. (2002) Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J. Neurosci. 22: 6458-6470
136. Anzini P., Neuberg D. H., Schachner M., Nelles E., Willecke K., Zielasek J. et al. (1997) Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 17: 4545-4551
137. Abrams C. K., Oh S., Ri Y. and Bargiello T. A. (2000) Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res. Brain Res. Rev. 32: 203-214
138. Yum S. W., Kleopa K. A., Shumas S. and Scherer S. S. (2002) Diverse trafficking abnormalities of connexin32 mutants causing CMTX. Neurobiol. Dis. 11: 43-52
139. VanSlyke J. K. and Musil L. S. (2002) Dislocation and degradation from the ER are regulated by cytosolic stress. J. Cell Biol. 157: 381-394
140. VanSlyke J. K., Deschenes S. M. and Musil L. S. (2000) Intracellular transport, assembly and degradation of wild-type and disease-linked mutant gap junction proteins. Mol. Biol. Cell 11: 1933-1946
141. Abel A., Bone L. J., Messing A., Scherer S. S. and Fischbeck K. H. (1999) Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. J. Neuropathol. Exp. Neurol. 58: 702-710
142. Baxter R. V., Ben Othmane K., Rochelle J. M., Stajich J. E., Hulette C., Dew-Knight S. et al. (2001) Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat. Genet. 30: 21-22
143. Ben Othmane K., Hentati F., Lennon F., Ben Hamida C., Blel S., Roses A. et al. (1993) Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum. Mol. Gen. 2: 1625-1628
144. Ben Othmane K. B., Loeb D., Hayworth-Hodgte R., Hentati F., Rao N., Roses A. D. et al. (1995) Physical and genetic mapping of the CMT4A locus and exclusion of PMP-2 as the defect in CMT4A. Genomics 28: 286-290
145. Nelis E., Erdem S., Van Den Bergh P. Y., Belpaire-Dethiou M. C., Ceuterick C., Van Gerwen V. et al. (2002) Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology 59: 1865-1872
146. Cuesta A., Pedrola L., Sevilla T., Garcia-Planells J., Chumillas M. J., Mayordomo F. et al. (2001) The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat. Genet. 30: 22-25
147. Boerkoel C. F., Takashima H., Nakagawa M., Izumo S., Armstrong D., Butler I. et al. (2003) CMT4A: identification of a Hispanic GDAP1 founder mutation. Ann. Neurol. 53: 400-405
148. Senderek J., Bergmann C., Ramaekers V. T., Nelis E., Bernert G., Makowski A. et al. (2003) Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. Brain 126: 642-649
149. Liu H., Nakagawa T., Kanematsu T., Uchida T. and Tsuji S. (1999) Isolation of 10 differentially expressed cDNAs in differentiated Neuro2a cells induced through controlled expression of the GD3 synthase gene. J. Neurochem. 72: 1781-1790
150. Ischiropoulos H. and Beckman J. S. (2003) Oxidative stress and nitration in neurodegeneration: cause, effect or association? J. Clin. Invest. 111: 163-169
151. Bolino A., Muglia M., Conforti F. L., LeGuern E., Salih M. A., Georgiou D. M. et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25: 17-19
152. Houlden H., King R. H., Wood N. W., Thomas P. K. and Reilly M. M. (2001) Mutations in the 5′ region of the myorubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. Brain 124: 907-915
153. Quattrone A., Gambardella A., Bono F., Aguglia U., Bolino A., Bruni A. C. et al. (1996) Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic and genetic aspects of a large family. Neurology 46: 1318-1324
154. Bolino A., Marigo V., Ferrera F., Loader J., Romio L., Leoni A. et al. (2002) Molecular characterization and expression analysis of-Mtmr2, mouse homologue of MTMR2, the myotubularin-related 2 gene, mutated in CMT4B. Gene 283: 17-26
155. Berger P., Bonneick S., Willi S., Wymann M. and Suter U. (2002) Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum. Mol. Genet. 11: 1569-1579
156. Wishart M. J. and Dixon J. E. (2002) PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. Phosphatase and tensin homolog deleted on chromosome ten. Trends Cell Biol. 12: 579-585
157. Schaletzky J., Dove S. K., Short B., Lorenzo O., Clague M. J. and Barr F. A. (2003) Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Curr. Biol. 13: 504-509
158. Kim S. A., Taylor G. S., Torgersen K. M. and Dixon J. E. (2002) Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease. J. Biol. Chem. 277: 4526-4531
159. Laporte J., Blondeau F., Gansmuller A., Lutz Y., Vonesch J. L. and Mandel J. L. (2002) The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J. Cell Sci. 115: 3105-3117
160. Walker D. M., Urbe S., Dove S. K., Tenza D., Raposo G. and Clague M. J. (2001) Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity. Curr. Biol. 11: 1600-1605
161. Simonsen A., Wurmser A. E., Emr S. D. and Stenmark H. (2001) The role of
162. Reggiori F. and Klionsky D. J. (2002) Autophagy in the eukaryotic cell. Eukaryot. Cell 1: 11-21
163. Gamp A. C., Tanaka Y., Lullmann-Rauch R., Wittke D., D'Hooge R., De Deyn P. P. et al. (2003) LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum. Mol. Genet. 12: 631-646
164. Nelis E., Erdem S., Tan E., Lofgren A., Ceuterick C., De Jonghe P. et al. (2002) A novel homozygous missense mutation in the myorubularin-related protein 2 gene associated with recessive Charcot-Marie-Tooth disease with irregularly folded myelin sheaths. Neuromuscul. Disord. 12: 869-873
165. Senderek J., Bergmann C., Weber S., Ketelsen U. P., Schorle H., Rudnik-Schoneborn S. et al. (2003) Mutation of the SBF2 gene, encoding a novel member of the myorubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet. 12: 349-356
166. Azzedine H., Bolino A., Taieb T., Birouk N., Di Duca M., Bouhouche A. et al. (2003) Mutations in MTMR13, a new pseudo-phosphatase homologue of MTMR2 and Sbf1, are responsible for an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am. J. Hum. Genet. 72: 1141-1153
167. Nandurkar H. H., Caldwell K. K., Whisstock J. C., Layton M. J., Gaudet E. A., Norris F. A. et al. (2001) Characterization of an adapter subunit to a phosphatidylinositol (3)P 3-phosphatase: identification of a myotubularin-related protein lacking catalytic activity Proc. Natl. Acad. Sci. USA 98: 9499-9504.
168. Kalaydjieva L., Nikolova A., Turnev I., Petrova J., Hristova A., Ishpekova B. et al. (1998) Hereditary motor and sensory neuropathy - Lom, a novel demyelinating neuropathy associated with deafness in gypsies. Clinical, electrophysiological and nerve biopsy findings. Brain 121: 399-408
169. Kalaydjieva L., Gresham D., Gooding R., Heather L., Baas F., de Jonge R. et al. (2000) N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am. J. Hum. Genet. 67: 47-58
170. Lachat P., Shaw P., Gebhard S., Van Belzen N., Chaubert P. and Bosman F. T. (2002) Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem. Cell Biol. 118: 399-408
171. Qu X., Zhai Y., Wei H., Zhang C., Xing G., Yu Y. et al. (2002) Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol. Cell. Biochem. 229: 35-44
172. Shaw E., McCue L. A., Lawrence C. E. and Dordick J. S. (2002) Identification of a novel class in the alpha/beta hydrolase fold superfamily: the N-myc differentiation-related proteins. Proteins 47: 163-168
173. Agarwala K. L., Kokame K., Kato H. and Miyata T. (2000) Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. Biochem. Biophys. Res. Commun. 272: 641-647
174. Gillespie C. S., Sherman D. L., Fleetwood-Walker S. M., Cottrell D. F., Tait S., Garry E. M. et al. (2000) Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26: 523-531
175. Delague V., Bareil C., Tuffery S., Bouvagnet P., Chouery E., Koussa S. et al. (2000) Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate gene. Am. J. Hum. Genet. 67: 236-243
176. Boerkoel C. F., Takashima H., Stankiewicz P., Garcia C. A., Leber S. M., Rhee-Morris L. et al. (2001) Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am. J. Hum. Genet. 68: 325-333
177. Guilbot A., Williams A., Ravise N., Verny C., Brice A., Sherman D. L. et al. (2001) A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum. Mol. Genet. 10: 415-421
178. Takashima H., Boerkoel C. F., De Jonghe P., Ceuterick C., Martin J. J., Voit T. et al. (2002) Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann. Neurol. 51: 709-715
179. Gillespie C. S., Sherman D. L., Blair G. E. and Brophy P. J. (1994) Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12: 497-508
180. Scherer S. S., Xu Y. T., Bannerman P. G., Sherman D. L. and Brophy P. J. (1995) Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development. Development 121: 4265-4273
181. Sherman D. L., Fabrizi C., Gillespie C. S. and Brophy P. J. (2001) Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30: 677-687
182. Sherman D. L. and Brophy P. J. (2000) A tripartite nuclear localization signal in the PDZ-domain protein L-periaxin. J. Biol. Chem. 275: 4537-4540
183. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S. et al. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105: 587-597
184. Mok H., Shin H., Kim S., Lee J. R., Yoon J. and Kim E. (2002) Association of the kinesin superfamily motor protein KIF1Balpha with postsynaptic density-95 (PSD-95), synapse-associated protein-97 and synaptic scaffolding molecule PSD-95/discs large/zona occludens-1 proteins. J. Neurosci. 22: 5253-5258
185. Miki H., Setou M., Kaneshiro K. and Hirokawa N. (2001) All kinesin superfamily protein, KIF, genes in mouse and human. Proc. Natl. Acad. Sci. USA 98: 7004-7011
186. Nangaku M., Sato-Yoshitake R., Okada Y., Noda Y., Takemura R., Yamazaki H. et al. (1994) KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79: 1209-1220
187. Brownlees J., Ackerley S., Grierson A. J., Jacobsen N. J., Shea K., Anderton B. H. et al. (2002) Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet. 11: 2837-2844
188. Auer-Grumbach M., De Jonghe P., Wagner K., Verhoeven K., Hartung H. P. and Timmerman V. (2000) Phenotype-genotype correlations in a CMT2B family with refined 3q13-q22 locus. Neurology 55: 1552-1557
189. Elliott J. L., Kwon J. M., Goodfellow P. J. and Yee W. C. (1997) Hereditary motor and sensory neuropathy IIB: clinical and electrodiagnostic characteristics. Neurology 48: 23-28
190. De Jonghe P., Timmerman V., FitzPatrick D., Spoelders P., Martin J. J. and Van Broeckhoven C. (1997) Mutilating neuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family. J. Neurol. Neurosurg. Psychiatry 62: 570-573
191. Verhoeven K., De Jonghe P., Coen K., Verpoorten N., Auer-Grumbach M., Kwon J. M. et al. (2003) Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am. J. Hum. Genet. 72: 722-727
192. Chaouch M., Allal Y., De Sandre-Giovannoli A., Vallat J. M., Amer-el-Khedoud A., Kassouri N. et al. (2003) The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene. Neuromuscul. Disord. 13: 60-67
193. De Sandre-Giovannoli A., Chaouch M., Kozlov S., Vallat J. M., Tazir M., Kassouri N. et al. (2002) Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 70: 726-736
194. Hutchison C. J. (2002) Lamins: building blocks or regulators of gene expression? Nat. Rev. Mol. Cell. Biol. 3: 848-858
195. Mersiyanova I. V., Perepelov A. V., Polyakov A. V., Sitnikov V. F., Dadali E. L., Oparin R. B. et al. (2000) A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67: 37-46
196. De Jonghe P., Mersivanova I., Nelis E., Del Favero J., Martin J. J., Van Broeckhoven C. et al. (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann. Neurol. 49: 245-249
197. Yoshihara T., Yamamoto M., Hattori N., Misu K., Mori K., Koike H. et al. (2002) Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot-Marie-Tooth disease patients and normal individuals. J. Peripher. Nerv. Syst. 7: 221-224
198. Jordanova A., De Jonghe P., Boerkoel C. F., Takashima H., De Vriendt E., Ceuterick C. et al. (2003) Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 126: 590-597
199. Fabrizi C., Kelly B. M., Gillespie C. S., Schlaepfer W. W., Scherer S. S. and Brophy P. J. (1997) Transient expression of the neurofilament proteins NF-L and NF-M by Schwann cells is regulated by axonal contact. J. Neurosci. Res. 50: 291-299
200. Zhu Q., Couillard-Despres S. and Julien J. P. (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148: 299-316
201. Lee M. K. and Cleveland D. W. (1994) Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr. Opin. Cell Biol. 6: 34-40
202. Perez-Olle R., Leung C. L. and Liem R. K. (2002) Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J. Cell Sci. 115: 4937-4946
203. Al-Chalabi A. and Miller C. C. (2003) Neurofilaments and neurological disease. Bioessays 25: 346-355
204. Frei R., Motzing S., Kinkelin I., Schachner M., Koltzenburg M. and Martini R. (1999) Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J. Neurosci. 19: 6058-6067
205. Witt A. and Brady S. T. (2000) Unwrapping new layers of complexity in axon/glial relationships. Glia 29: 112-117
206. Maurer M., Kobsar I., Berghoff M., Schmid C. D., Carenini S. and Martini R. (2002) Role of immune cells in animal models for inherited neuropathies: facts and visions. J. Anat. 200: 405-414
207. Nagarajan R., Le N., Mahoney H., Araki T. and Milbrandt J. (2002) Deciphering peripheral nerve myelination by using Schwann cell expression profiling. Proc. Natl. Acad. Sci. USA 99: 8998-9003